Pre-Eclampsia
Conditions
Brief summary
This entry was submitted in error by DiaMedica Therapeutics, Inc. and was not authorized by any of the trial Investigators or study sponsor (Stellenbosch University). The clinical trial, DM199 for Pregnancy Complications, was prospectively registered with the Pan African Clinical Trials Registry (PACTR202404895013782), in accordance with ICMJE and WHO requirements. This listing serves as the primary and authoritative registration record for this investigator-initiated study.
Interventions
BIOLOGICALDM199
DM199 is a synthetic form of rhKLK1
Sponsors
DiaMedica Therapeutics Inc
Study design
Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
Please refer to the Pan African Clinical Trials Registry (PACTR202404895013782).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of treatment adverse events | Until 6 weeks after the due date |
Outcome results
None listed